VNI (molecule)

A chemical compound used in antifungal treatments

Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms	[[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704	[[File:|50px]]
References

VNI is a chemical compound that has been studied for its potential use in antifungal treatments. It is known for its ability to inhibit the enzyme lanosterol 14_-demethylase, which is crucial in the biosynthesis of ergosterol, an essential component of fungal cell membranes.

Chemical Structure

VNI is characterized by its complex molecular structure, which includes several functional groups that contribute to its biological activity. The molecule is designed to interact specifically with the active site of lanosterol 14_-demethylase, thereby blocking the synthesis of ergosterol.

Mechanism of Action

The primary mechanism by which VNI exerts its antifungal effects is through the inhibition of lanosterol 14_-demethylase. This enzyme is part of the cytochrome P450 family and plays a critical role in the conversion of lanosterol to ergosterol. By inhibiting this enzyme, VNI disrupts the production of ergosterol, leading to increased membrane permeability and ultimately cell death in fungi.

Research and Development

VNI has been the subject of various studies aimed at evaluating its efficacy and safety as an antifungal agent. Research has shown that VNI is effective against a range of fungal pathogens, including species of Candida and Aspergillus. Its potential use in treating Chagas disease has also been explored, given its ability to inhibit similar enzymes in the causative parasite, Trypanosoma cruzi.

Potential Applications

The development of VNI as a therapeutic agent is ongoing, with studies focusing on its pharmacokinetics, toxicity, and potential for resistance development. Its broad-spectrum activity makes it a promising candidate for treating systemic fungal infections, particularly in immunocompromised patients.

Related Pages

• Antifungal drug
• Ergosterol
• Cytochrome P450
• Chagas disease